APA (7th ed.) Citation

Chanchlani, R., & Kirschfink, M. (2018). Long-term Eculizumab therapy in a child with refractory immune complex-mediated membranoproliferative glomerulonephritis. Kidney international. Reports, 3(2), . https://doi.org/10.1016/j.ekir.2017.08.019

Chicago Style (17th ed.) Citation

Chanchlani, Rahul, and Michael Kirschfink. "Long-term Eculizumab Therapy in a Child with Refractory Immune Complex-mediated Membranoproliferative Glomerulonephritis." Kidney International. Reports 3, no. 2 (2018). https://doi.org/10.1016/j.ekir.2017.08.019.

MLA (9th ed.) Citation

Chanchlani, Rahul, and Michael Kirschfink. "Long-term Eculizumab Therapy in a Child with Refractory Immune Complex-mediated Membranoproliferative Glomerulonephritis." Kidney International. Reports, vol. 3, no. 2, 2018, https://doi.org/10.1016/j.ekir.2017.08.019.